Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions
Drug conjugates are obtained from tumor-located vectors connected to cytotoxic agents via linkers, which are designed to deliver hyper-toxic payloads directly to targeted cancer cells. These drug conjugates include antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), small molecule-drug...
Saved in:
Main Authors: | Cuiping Li (Author), Kourong Shi (Author), Siyuan Zhao (Author), Juan Liu (Author), Qiaoli Zhai (Author), Xiaoli Hou (Author), Jie Xu (Author), Xinyu Wang (Author), Jiahui Liu (Author), Xin Wu (Author), Wei Fan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody-drug conjugates: Recent advances in payloads
by: Zhijia Wang, et al.
Published: (2023) -
Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload
by: Aleksei Kondrashov, et al.
Published: (2023) -
Development of bombesin-tubulysin conjugates using multicomponent chemistry to functionalize both the payload and the homing peptide
by: Dayma Llanes, et al.
Published: (2024) -
Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency
by: Dian Su, et al.
Published: (2021) -
Antibody-drug conjugates: Recent advances in linker chemistry
by: Zheng Su, et al.
Published: (2021)